Copyright
©The Author(s) 2019.
World J Gastrointest Endosc. Feb 16, 2019; 11(2): 155-167
Published online Feb 16, 2019. doi: 10.4253/wjge.v11.i2.155
Published online Feb 16, 2019. doi: 10.4253/wjge.v11.i2.155
Year | Ref. | Patients, n | Design | Device | EHL/LL | Success rate | AE % | Follow-up in mo |
1999 | Howell et al[14] | 6 | R/M | M-B | EHL | 83 | 0 | 6 |
2009 | Fishman et al[51] | 6 | R/M | Spyglass® | EHL | 50 | 0 | NA |
2011 | 2Maydeo et al[21] | 4 | P/S | Spyglass® | LL | 100 | 13.3 | 1 |
2013 | Alatawi et al[12] | 5 | P/S | Spyglass® | LL | 80% | 0 | 21 |
2014 | Attwel et al[19] | 46 | R/S | Olympus M-B (31) vs Spyglass® (15) | LL/EHL1 | 68 vs 73 (scope type) | 10 | 18 |
2014 | Ito et al[23] | 8 | R/S | Spyglass® | EHL1 | 37.5 | 25 | NA |
2015 | Attwell et al[9] | 28 | R/M | Spyglass® | LL1 | 79 | 29 | 13 |
2016 | 2Navaneethan et al[52] | 5 | R/M | Spyglass® | LL | 80 | 0 | NA |
2017 | Bekkali et al[53] | 6 | R/S | Spyglass® | EHL | 83 | 0 | 30 |
2017 | Parbhu et al[22] | 20 | R/M | Spyglass® | EHL/LL | 85 | 7.3 | NA |
Year | Ref. | N | Design | Key findings | Adjunct modalities/success | AE% | Follow up |
1997 | Uehara et al[42] | 11 | P | Made early diagnosis of CIS missed by other modalities | Cytology in all (with secretin) | NR | 34 mo |
1998 | Jung et al[39] | 18 | P | Visual differentiation - IPMN, Cancer, Chr pancreatitis | Cytology in all | 6 | 2 yr |
1998 | Mukai et al[47] | 25 | R/S | Papillary lesions > 3 mm, trend towards malignancy | IDUS (> sensitive than POP) for detecting protrusions > 3 mm | 4 | NA |
1998 | Tajiri et al[54] | 52 | P | Visual intraductal findings to differentiate Chr pancreatitis and neoplaisa | 81% success | 3.8 | NA |
2000 | Yamaguchi et al[27] | 41 | R/S | Villious/vegetative lesions with red marks correlate with atypical adenoma/cancer | 73.2% success | NA | 38.5 mo |
2002 | Kodama et al[37] | 42 | P | POP correctly identified all stenosis due to Chr pancreatitis | 75% success | 1.8 | NA |
2002 | Hara et al[33] | 60 | R/S | POP + IDUS 88% accuracy in differentiating benign vs malignant POP better for MD type, IDUS better for SB type | IDUS in 40 patients Cytology in 36 patients - Low Sens 13% | 7 | 38.4 mo |
2003 | Yamao et al[41] | 115 | R | Protrusion, friability 100% spec for malignant stenosis | 83% success (lower for pancreatic tumor > 2 cm) | 12 | 2 yr |
2005 | Yamaguchi et al[43] | 103 | R/S | Cytology has better diagnostic value when collected by POP vs catheter Better for MD type vs SB type | Cytology in 32 with POP, 71 via catheter | NR | 18 mo |
2005 | Yasuda et al[36] | 26 | R | IDUS 100% Sens for lesions > 3 mm, POP Sens 67% No carcinoma in protrusions < 3 mm Biopsy Sens 50% for cancer | IDUS | 0 | NA |
2010 | Miura et al[48] | 21 | R/S | Protrusions and vascular patterns seen better with NBI as compared to white light | Narrow Band imaging (NBI) Technical success 90% | 0 | 2 yr |
2014 | Arnelo et al[34] | 44 | P/S | Spyglass Sens 84%, spec 75% Acc for MD type 76% Acc for BD type 78% | Obtained - Brushings in 88% Biopsy in 41% | 17 | 2.3 yr |
2014 | Nagayoshi et al[35] | 17 | R/S | Sens for detecting malignancy Irrigation Cytology Sens 100% Biopsy Sens 25% | Cytology | 35 - mild | 18.8 mo |
2017 | Parbhu et al[22] | 16 | R/M | Accuracy Biopsy 63.7% Biopsy + Visual 100% | Technical success for biopsy 100% | 7.3 | 6 mo |
2017 | El Hajj et al[38] | 79 | R/S | Accuracy Visual 87% Visual + tissue 94% (combination) | Technical success 97% Tissue acquisition was combination of brushings, POP assisted and POP directed biopsy | 12 | 12 mo (minimum) |
IPMN | Adenocarcinoma | Chronic pancreatitis | |
Uehara et al[42] | Papillary projections, irregular/nodular mucosa | ||
Jung et al[39] | Papillary projections; Villous protrusions | Tumor vessels; Erosions | Smooth narrowing; White/gray mucosa; Blurred blood vessels |
Tajiri et al[54] | Papillary projections; Salmon eggs | Protrusions; Tumor vessels; Friability, erosions | Protein plugs/stones; Edema, erythema, scar |
Yamaguchi et al[27] | (1) Hyperplasia/Mild atypia; sessile or semi pedunculated with white color markings; (2) Severe atypia/adenocarcinoma semi pedunculated or villous or vegetative with red color markings | ||
Kodama et al[37] | Papillary projections; Nodular/villous; White/spotty/red marks | Duct cut off; Friability/erosions | Stones, proteins plugs; Scar, erythema; Blurred vessels |
Hara et al[33] | CIS/Invasive carcinoma; salmon eggs with vascular pattern; Villous/vegetative protrusions | ||
Yamao et al[41] | Coarse, granular papillary projections with mucus | Papillary projection with tumor vessels; Protrusion/friability | Coarse erythema |
Miura et al[48] | (1) High risk - villous/vegetative with tumor vessel; (2) Low risk - sessile / semi pedunculated | ||
El Hajj et al[38] | (1) Invasive - villous/vegetative papillary projections; (2) Noninvasive - granular projections with erythema | Protrusion with tumor vessel; Ulceration; Infiltrative stricture | Coarse, blurred vessels, scarring, erythema and edema |
- Citation: Kaura T, Willingham FF, Chawla S. Role of pancreatoscopy in management of pancreatic disease: A systematic review. World J Gastrointest Endosc 2019; 11(2): 155-167
- URL: https://www.wjgnet.com/1948-5190/full/v11/i2/155.htm
- DOI: https://dx.doi.org/10.4253/wjge.v11.i2.155